Plozalizumab, CAS 1610761-46-0

Product Description: Plozalizumab (MLN-1202) is a specific humanized anti-CCR2 antibody. Plozalizumab can be used for malignant melanoma research[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Jahchan NS, et al. Tuning the Tumor Myeloid Microenvironment to Fight Cancer. Front Immunol. 2019 Jul 25;10:1611.

CAS Number: 1610761-46-0

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer

Solubility: H2O

Target: CCR

• Artikelnummer: MEXHY-P99781-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99781-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated